Domov › Rak želodca › Illinois › Chicago
Klinične študije za Rak želodca v Chicago, IL
16 študij za Rak želodca išče udeležence na lokacijah v Chicago in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- in še 1
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- University of Illinois Cancer Center, Chicago
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Vključevanje udeležencevFaza 2/3
- Local Institution - 0379, Chicago
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Vključevanje udeležencevFaza 2/3
- Illinois Cancer Specialists, Chicago
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Vključevanje udeležencevFaza 1
- University of Illinois Cancer Center, Chicago
- University of Chicago Medicine, Chicago
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Vključevanje udeležencevFaza 3
- Research Site, Chicago
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Vključevanje udeležencevFaza 1
- University of Chicago, Chicago
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
Vključevanje udeležencevFaza 2
- University of Chicago, Chicago
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- University of Chicago Medical Center, Chicago
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Vključevanje udeležencevFaza 1
- University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
- University of Chicago Medical Center /ID# 276271, Chicago
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1/2
- University of Chicago Medical Center, Chicago
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Vključevanje udeležencevFaza 3
- Northwestern University, Chicago
- University of Chicago, Chicago
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
Vključevanje udeležencevFaza 1/2
- University of Chicago, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Chicago
Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
Vključevanje udeležencevOpazovalna študija
- The University of Chicago, Chicago
A Study of NX-1607 in Adults With Advanced Malignancies
Vključevanje udeležencevFaza 1
- University of Chicago, Chicago
Študije za Rak želodca v drugih mestih
- Houston, TX42 študij
- Boston, MA32 študij
- New York City, NY31 študij
- Nashville, TN28 študij
- Baldwin Park, CA22 študij
- Los Angeles, CA22 študij
- Arlington, VA20 študij
- Dallas, TX19 študij
- San Antonio, TX19 študij
- St. Louis, MO18 študij
- Grand Rapids, MI18 študij
- Washington, DC16 študij
Druge študije v Chicago
- Nemalicelični pljučni rak61 študij
- Rak dojke59 študij
- Rak (vse vrste)51 študij
- Metastatski rak45 študij
- Rak prostate45 študij
- Rak pljuč41 študij
- Debelost41 študij
- Rak jajčnikov36 študij
- Kolorektalni rak34 študij
- Možganska kap34 študij
- Srčno popuščanje31 študij
- Prekomerna telesna teža29 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.